Study suggests COVID-19 vaccination lowers incidence of arterial thromboses
A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke
Read Moreby Jen Brogan | Aug 12, 2024 | News | 0
A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke
Read Moreby Jen Brogan | Aug 8, 2024 | News | 0
The study predicted the development of conditions including Alzheimer’s and heart disease
Read Moreby Jen Brogan | Jul 29, 2024 | News | 0
Coronary heart disease is the most common form of heart and circulatory disease
Read Moreby Jen Brogan | Jul 19, 2024 | News | 0
Chronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read Moreby Jen Brogan | Jul 2, 2024 | News | 0
According to WHO, around 15% of pregnant women will develop an obstetric complication
Read Moreby John Pinching | Jun 5, 2024 | News | 0
Extended phase 2 study highlights macrophage cell therapy’s efficacy
Read Moreby Jen Brogan | Apr 26, 2024 | News | 0
The new method could help to prevent severe side effects caused by enantiomer drugs
Read Moreby Jen Brogan | Apr 22, 2024 | News | 0
The neurodegenerative condition currently affects more than 944,000 people living in the UK
Read Moreby Jen Brogan | Apr 4, 2024 | News | 0
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Read Moreby Jen Brogan | Mar 5, 2024 | News | 0
Women with atypical endometrial hyperplasia have an increased risk of developing cancer
Read Moreby Jen Brogan | Jan 10, 2024 | News | 0
The £30m ADVANCE study is the most extensive study into liver disease worldwide
Read Moreby Jen Brogan | Oct 27, 2023 | News | 0
Around 145,000 people in the UK are living with Parkinson’s disease
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
